Results 161 to 170 of about 260,978 (272)

Journey to Net‐Zero and Investment in Renewable Energy: Evidence From Developed and Developing Countries

Business Strategy and the Environment, EarlyView.
ABSTRACT This study examines how geopolitical risk, high‐technology exports and the Paris Agreement shape investment in renewable energy across developed and developing economies. Drawing on structural contingency theory, we conceptualise renewable energy investment as a country‐level response to external contingencies and analyse a global panel of 100
Tianqi Luo, Konstantinos Baltas, Ranadeva Jayasekera, Thanos Papadopoulos, Gazi Salah Uddin, Donghyun Park   +5 more
wiley   +1 more source

Molecular Signaling Pathways, Regulatory and Coactivator Networks, and Emerging Mechanisms in Hepatocellular Carcinoma. [PDF]

Biomedicines
Srivastava RK, Singh P, Lonard DM.
europepmc   +1 more source

From ‘Responsible’ to ‘Sustainable’: A Contingent Analysis of Responsible Entrepreneurship and Product Innovation Performance in an Emerging Economy

Business Strategy and the Environment, EarlyView.
ABSTRACT While debate on responsible entrepreneurial activities for sustainable development is burgeoning, studies examining whether small and medium‐sized firms (SMEs) can benefit from responsible entrepreneurship remain underexplored. In this study, we draw on stakeholder theory to fill this literature gap by investigating the effect of responsible ...
Ayodele C. Oniku, Awele Achi, Adejumoke Adeoti, Olamide O. Akintimehin, Francis Chukwuedo Achi, Solomon Jeresa, Benard Iyegudu   +6 more
wiley   +1 more source

Estrogen Suppresses Osteoclast Function and Cytoskeletal Remodeling via Modulation of the RhoA-Pkn3-c-Src Signaling Pathway in Ovariectomized Rats. [PDF]

Biology (Basel)
Wang Y, Yang S, Yuan Y, Fan D, Zhao H, Liu M.   +5 more
europepmc   +1 more source

Transformation Teams Leading the Hispanic‐Serving Institutions Movement at HSI Community Colleges

New Directions for Community Colleges, EarlyView.
ABSTRACT The Department of Education defunded discretionary grant programs for enrollment‐based minority‐serving institutions (MSIs) on September 10, 2025, yet Hispanic‐serving institutions (HSIs) still exist and must continue to adapt to their growing population of Latine/x students.
Gina Ann Garcia, Flor Huerta, Julio R. Flores   +2 more
wiley   +1 more source

Hispidulin Suppresses Hepatocellular Carcinoma Proliferation by Targeting PI3K-Akt Pathway: A Network Pharmacology and Experimental Validation Study. [PDF]

J Hepatocell Carcinoma
Zhang X, Yang Y, Xu Z, Chen M, Yang A, Yang Y.   +5 more
europepmc   +1 more source

Genomic Insights Into Risperidone Treatment Outcomes in Children and Adolescents: Experience From a Psychiatric Hospital Serving Rural Youth

Clinical Pharmacology &Therapeutics, EarlyView.
Risperidone is a commonly used antipsychotic for treating psychiatric illness in children and adolescents. There is a large variability in risperidone response and discontinuation rates remain high. Pharmacogenomics offers the opportunity to improve risperidone outcomes, yet studies in pediatric populations are limited.
Jack W. Staples, Shayna R. Killam, Karen E. Brown, Rachel Dalton, Elizabeth Sather, Qiang Chen, Joshua Loveland, Corbin Schwanke, Abdallah F. Elias, Kristin L. Bigos, Erica L. Woodahl   +10 more
wiley   +1 more source

BiTtEn by Src inhibitors [PDF]

Blood, 2021
openaire   +2 more sources

Slap restricts oncogenic Src-family kinase signaling to maintain colonic epithelial homeostasis. [PDF]

Elife
Naim D, Houhou Z, Cauchois F, Espie K, Simon V, Boublik Y, Langa Vives F, Homayed Z, Paul C, Maillard M, Hahne M, Pannequin J, Nguyen J, Sirvent A, Roche S.   +14 more
europepmc   +1 more source

Intravenous Lipopolysaccharide Challenge in Healthy Participants Reveals Pharmacodynamic Markers in Blood and Bone Marrow for Early‐Phase Oncology Drug Development

Clinical Pharmacology &Therapeutics, EarlyView.
Demonstrating pharmacological effects in early‐phase oncology clinical trials remains challenging, largely due to the lack of robust pharmacodynamic markers. Lipopolysaccharide (LPS) is used as an immune challenge agent in healthy participants to study drugs for autoimmune conditions.
Igor Radanović, Ingrid Tomljanović, Wieke H. Grievink, Diana R. Pereira, Michelle Osse, Peter van Balen, Maria J. Juachon, Marieke L. de Kam, Lisa Pagan, Manon A.A. Jansen, Matthijs Moerland, Jacobus J. Bosch   +11 more
wiley   +1 more source